Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Organigram Holdings Inc (TSX: OGI )

1.660 -0.010 (-0.60%)
Streaming Delayed Price Updated: 3:59 PM EST, Feb 26, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 125,201
Open 1.680
Bid (Size) 1.650 (173)
Ask (Size) 1.700 (520)
Prev. Close 1.670
Today's Range 1.660 - 1.720
52wk Range 1.660 - 3.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Organigram Reports First Quarter Fiscal 2025 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram to Report First Quarter Fiscal 2025 Results on February 11, 2025
From Organigram Holdings Inc.
Via Business Wire

Performance

YTD
-31.40%
-31.40%
1 Month
-24.20%
-24.20%
3 Month
-20.95%
-20.95%
6 Month
-33.06%
-33.06%
1 Year
-42.96%
-42.96%

More News

Read More
Organigram Reports Fourth Quarter and Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram to Report Fourth Quarter and Fiscal 2024 Results on December 18, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Wants To Become Canada's Largest Cannabis Company By Market Share Via $71M Acquisition Deal
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Acquires Motif, Becoming Canada’s Largest Cannabis Company by Market Share
From Organigram Holdings Inc.
Via Business Wire
Organigram Launches FAST™ Nanoemulsion Gummies
From Organigram Holdings Inc.
Via Business Wire
Tobacco Giant Invests $30.8M In Cannabis Company: BAT Private Placement Second Of Three Tranches
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Closes Second Tranche of Previously Announced BAT Private Placement Investment
From Organigram Holdings Inc.
Via Business Wire
CEO Shake-Ups At Canopy, Curaleaf And Recent Top Exec And Board Changes In Cannabis And Psychedelics
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Reports 25% YoY Increase In Q3 Net Revenue, Significant Improvement In Adjusted EBITDA
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Reports Third Quarter Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram Product Development Collaboration Completes Landmark Clinical Study on Nanoemulsion Technology
From Organigram Holdings Inc.
Via Business Wire
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram to Report Third Quarter Fiscal 2024 Results on August 13, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Announces Appointment of Craig Harris to Board of Directors
From Organigram Holdings Inc.
Via Business Wire
Organigram to Bolster Auto-Flower and Rare Cannabinoid Portfolio with Partial Third Tranche Investment of US $1M into Phylos
From Organigram Holdings Inc.
Via Business Wire
Organigram Supports Cannabis In Germany With $15M Initial Investment In This Berlin Marijuana Co.
Via Benzinga
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
Organigram Invests in Sanity Group, a Leading German Cannabis Company
From Organigram Holdings Inc.
Via Business Wire
Organigram And This Canadian Cannabis Brand Expand In Europe And Beyond
Via Benzinga
Topics Cannabis
Exposures Cannabis
Organigram Signs Three Year Supply Agreement with Avida Medical in UK
From Organigram Holdings Inc.
Via Business Wire
Organigram Reports 262% Higher Quarterly Net Loss YoY, Makes Progress In International Markets
Via Benzinga
Organigram Reports Second Quarter Fiscal 2024 Results
From Organigram Holdings Inc.
Via Business Wire
Organigram to Report Second Quarter Fiscal 2024 Results on May 14, 2024
From Organigram Holdings Inc.
Via Business Wire
Organigram Recognized for Executive Gender Diversity by the Globe & Mail’s Women Lead Here Report for the Fourth Consecutive Year
From Organigram Holdings Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.